Back to Search
Start Over
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
- Source :
-
Leukemia (08876924) . Jan2013, Vol. 27 Issue 1, p252-255. 4p. 2 Charts. - Publication Year :
- 2013
-
Abstract
- The article discusses the study of patients with B-cell lymphoma for administration of lenalidomide in combination with rituximab (R2) and chemotherapy regimen (CHOP). First two cycles were evaluated for evaluation of lenalidomide. Patients from 18-70 years of age were included in the study and the dose of lenalidomide was given in combination with rituximab, doxorubicin, cyclophosphamide and vincristine. It was conclued that the efficacy of immunochemotherapy is increased by R2-CHOP.
- Subjects :
- *B cells
*LYMPHOMAS
*RITUXIMAB
*DRUG therapy
*DOXORUBICIN
Subjects
Details
- Language :
- English
- ISSN :
- 08876924
- Volume :
- 27
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Leukemia (08876924)
- Publication Type :
- Academic Journal
- Accession number :
- 84669827
- Full Text :
- https://doi.org/10.1038/leu.2012.172